Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-30

Clinical Trial Update: Clinical Trial of Novel OPV2 Vaccine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a novel OPV2 vaccine addressing poliomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPV2 vaccine

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Poliomyelitis | Phase 2 | Status: COMPLETED